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ABSTRACT   
 
BACKGROUND: Prevalence of tuberculosis in vulnerable groups 
such as prisoners is usually high, and the problem is worsened by 
poor treatment outcomes. In spite of this, there is limited 
information regarding tuberculosis in prisons of Ethiopia. Hence, 
this study was aimed to assess the prevalence of tuberculosis and 
treatment outcomes of patients with tuberculosis among inmates of 
Debrebirhan prison in North Shoa, Ethiopia. 
METHODS: A retrospective cross-sectional study was conducted 
among inmates of Debrebirhan prison. Data were collected by 
reviewing the medical charts and other records of prison inmates 
diagnosed and treated for tuberculosis between September 2010 
and August 2015. Data were entered and analyzed using SPSS 
version 21.0.  
RESULTS: A total of 162 patients with tuberculosis were registered 
and treated at Debrebirhan prison health center within the five 
years study period. The overall average prevalence was found to be 
32 per 1538 (2139 per 100,000) prison inmates. Regarding 
treatment outcome, 44(27.2%) were cured, 59(36.42%) completed 
treatment, 2(1.24%) were treatment failures, 6(3.72%) died and 
51(31.5%) were not evaluated. The five year’s treatment success 
rate was found to be 63.62%. Area of residence (AOR= 3.59; 95% 
CI:  1.44, 8.93), duration of imprisonment (AOR = 3.67; 95% CI: 
1.53, 8.78) and history of tuberculosis were significantly associated 
with treatment outcome of tuberculosis.  
CONCLUSION: This study showed high prevalence of tuberculosis 
in Debrebirhan prison. It also revealed that the treatment success 
rate of patients with tuberculosis was lower than the target set by 
World Health Organization.  
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Despite the availability of efficacious drugs, 
tuberculosis (TB) remains a major public health 
problem in low and middle income countries. 
Ninety-five percent of the global TB disease and 
TB death burden is found in poor countries of 
Africa and Eastern Europe. More than 80% of the 
global TB cases are found in 22 high burden 
countries (HBCs), including Ethiopia (1-3). 
According to the 2015 world health organization 
(WHO) global TB report, Ethiopia ranked seventh 
in the list of HBCs for TB, with an estimated 
prevalence of 200 cases per 100,000 persons and 
mortality rate of 32 per 100,000 (1).  The situation 
is worsened in prison populations with a very high 
prevalence ranging from 5 to 70 times higher than 
in the general population (4).  
The overall prevalence of smear positive 
pulmonary tuberculosis (PTB) infection was 5.3 % 
(15/282) in prison settings of North Gondar Zone 
(5). In a survey conducted in Hadiya Zone prison, 
the point prevalence of smear positive PTB was 
349.2 per 100,000 populations, about three times 
higher than in the general population (6). 
Cognizant of the burden of TB, countries like 
Ethiopia have given due attention to the control of 
TB by including the prevention and control of the 
case among the priority health programs aligning 
with the global plan to stop TB (7).  
Treatment outcome is an important indicator 
to evaluate the effect of TB prevention and control 
program (1). Globally, in 2012, the treatment 
success rate was 86% among all new TB cases and 
in the African region, it was 81%. Of the 22 
HBCs, 15 reached or exceeded a treatment success 
rate of 85% among all new cases in 2012.  In 
Ethiopia, treatment success rate for all new and 
relapse cases was 91% in 2012 and 89% in 2013 
(1, 2).  
Among the 244 patients who received 
treatment, 77% were cured, 5% died, 7% failed, 
and 12% defaulted (8). In a study conducted in 
Debre Berhan Hospital, 1016(79.4%) had 
successful treatment outcome. Of these, 203(20%) 
and 813(80%) patients were cured and treatment 
completed, respectively (9). A retrospective study 
conducted in selected health facilities of Afar 
Regional State, Ethiopia, reported a treatment 
success of 81.8% (10).  
Hence, TB control programs should give 
emphasis towards prison health systems so as to 
increase case detection rate of TB and strengthen 
Direct Observation Therapy (DOT) program to 
improve the treatment success rate and to establish 
efficient referral and contact tracing mechanisms 
for transferred out cases (11). However, there is 
scarcity of information on prison health in 
Ethiopia and especially in the selected prison 
center (12). Therefore, this study was aimed to 
assess the prevalence of tuberculosis and treatment 
outcomes of tuberculosis among inmates of 
Debrebirhan prison, North Shoa, Ethiopia.  
 
MATERIALS AND METHODS 
 
Study area and setting: The study was conducted 
in a prison which is located in Debrebirhan city, 
central Ethiopia, North Shoa Zone of Amhara 
Region, which is about 130 km Northeast of Addis 
Ababa. Debrebirhan prison is one of the 30 
prisons in Amhara Regional State of Ethiopia. 
There were 1,692 (1,660 males and 32 females) 
prisoners during the data collection period which 
was between September 2010 and August 2015. 
The prison has a health center which provides 
basic curative and preventive health services to the 
prison inmates and the prison staff. It also 
provides TB diagnostic and treatment services. 
 
Study design: A retrospective cross-sectional 
study was conducted by reviewing the existing 
data of the prison inmates diagnosed and treated 
for tuberculosis between September 2010 and 
August 2015. All inmates of Debrebirhan prison 
were the source population, and all inmates of the 
prison who were on anti-tuberculosis during the 
study period were included in the study. 
 
Data collection and management: A data 
abstraction sheet was designed for collecting data 
of patients with TB who were included in the 
study. Medical charts like symptomatic TB 
screening registers, health management 
information system registers and laboratory 
registers were reviewed thoroughly to collect data 
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on age, sex, Human Immunodeficiency Virus 
(HIV)  status, type of TB diagnosed, previous TB 
history and treatment outcomes of TB. Additional 
data such as residence, educational status, duration 
of stay in prison and number of prisoners were 
obtained from the prisoners’ profiles kept in the 
prisoners’ administrator office. Data was collected 
by a trained clinical nurse between March 01, 
2016 and April 30, 2016. To ensure the quality of 
data collected, regular supervision was performed. 
Data entry and analysis: Before entry, data were 
coded and cleaned for consistency and 
completeness. The data was entered and analyzed 
using Statistical Package for Social Sciences 
(SPSS) version 21.0. Descriptive statistics 
including mean, percentage and standard 
deviations were computed for the survey data. 
Multivariable logistic regression was used to 
explore possible associations between the 
treatment outcome and other independent 
variables. 
 
Measurement: In this study, tuberculosis 
treatment outcome was dichotomized as 
successful treatment outcome (cured or treatment 
completed) or poor treatment outcome (treatment 
failure or death or not evaluated or transferred 
out). The following operational definitions were 
adapted (9). 
• Cured: patients whose sputum smear or 
culture was positive at the beginning of the 
treatment but smear or culture negative in the 
last month of treatment and on at least one 
previous occasion. 
• Treatment completed: patient who completed 
treatment without evidence of failure but 
with no record to show that sputum smear or 
culture results in the last month of treatment 
and on at least one previous occasion were 
negative. 
• Treatment failure: patients whose sputum 
smear or culture was positive at the fifth 
month or later during treatment. 
• Not evaluated: patient for whom no treatment 
outcome is assigned. This includes cases 
‘transferred-out’ to another treatment unit as 
well as cases for whom the treatment 
outcome is unknown to the reporting unit. 
• Died: patient who dies for any reason during 
the course of treatment.  
Ethical considerations: Ethical clearance of the 
study was granted from the Ethical Review Board 
of Africa Medical College (protocol number: 
MPH/AF-026/2016). Permission to conduct the 
research was also sought from the prison 
administrator. To maintain confidentiality and 
anonymity, data collector was recruited from the 
health center. There was no use of individual 
identifiers and the data obtained from the records 




Socio-demographic and clinical characteristics: 
The total number of inmates in Debrebirhan prison 
during the five years period was 7691, ranging 
from 1203 prisoners in 2010/11 to 1701 in 
2013/14, with a mean (for all the five years 
period) of 1538 prisoners.  Of these, a total of 162 
TB patients were registered at the prison health 
center between September 2010 and August 2015. 
Although there were few female prisoners, all of 
the 162 TB patients were males with mean age of 
30.2 +9.77 years, ranging between 15 and 56 
years. More than one-third (37.65%) of the 
patients were within the age category of 25-34 
years. Regarding their area of residence prior to 
their imprisonment, 97(59.88%) of the patients 
were rural residents (Table 1).  
Most (92.6%) of the patients were new TB 
cases, but there were also 3(1.9%) relapses and 
7(4.3%) transferred-in cases. Looking into the 
type of TB, the majority, 73(45.1%), of the 
patients were smear positive pulmonary TB 
followed by smear negative pulmonary TB 
patients, 66(40.7%). One hundred and fourteen 
(70.4%) of the TB patients were tested for HIV 
and 6 of them were found to be positive resulting 
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Table 1:  Socio-demographic and clinical 
characteristics of patients with TB in Debrebirhan 
prison, North Shoa Ethiopia; September 2010 – 
August 2015 (n = 162) 
 
 Variables Frequency Percent 
Sex 
 Male 162 100.0 
Age group (in years) 
 15-24 52 32.10 
 25-34 61 37.65 
 35-44  30 18.52 
  ≥45       19 11.73 
Residence 
 Rural 97 59.88 
 Urban 65 40.12 
Educational  Status 
 Below grade 5 76 46.9 
 Grades 5-10 70 43.2 
 Above grade 10 16 9.9 
Duration of Imprisonment 
 ≤2 years 66 40.74 
 >2 years 96 59.26 
HIV Status 
 Positive     6 3.7 
 Negative 108 66.7 
 Unknown 48 29.6 
Patient Category 
 New 150 92.6 
 Relapse      3 1.9 
 Treatment after 
failure 
   2 1.2 
 Transfer in    7 4.3 
Type of TB 
 Smear positive 
pulmonary  
73 45.1 
 Smear negative 
pulmonary 
66 40.7 
 Extra pulmonary 23 14.2 
Treatment Outcome 
 Cured  44 27.2 
 Treatment completed 59 36.4 
 Treatment failure  2 1.2 
 Not evaluated 51 31.5 
 Died         6 3.7 
 
Prevalence of Tuberculosis: During the study 
period, 162 TB cases were registered and the 
overall average prevalence was found to be 32 per 
1538 (2139 per 100,000) inmates. Higher TB 
prevalence was observed in the year of September 
2011-August 2012 which was 2553 per 100,000 
inmates. Then after this year, the prevalence was 
declining across the years (Table 2). 
Tuberculosis treatment outcomes among 
inmates of Debrebirhan prison: Treatment 
outcome of 162 patients with tuberculosis who 
were registered at Debrebirhan prison health 
center during the five years period were analyzed. 
While 103(63.42%) had successful treatment 
outcome (favorable treatment outcome), 
59(36.45%) had poor treatment outcome 
(unfavorable treatment outcome). From the 162 
TB patients, forty-four (27.2%) were cured, 
59(36.42%) had completed treatment, 2(1.24%) 
were treatment failure, 6(3.72%) died, 51(31.49%) 
were not evaluated (either transferred out or 
released before completing their treatment). The 
highest treatment success, 15.43%, was recorded 
in September 2011-August 2012 while the lowest, 
10.50% was observed in September 2010-August 
2011. On the other hand, 2(1.2%), 51(31.5%) and 
6(3.7%) were treatment failure, not evaluated and 
died, respectively (Table 3).  
While the maximum cured patients with TB, 
12(7.41%), was registered in September 2013- 
August 2014, the minimum 5(3.09%) was 
recorded in September 2010-August 2011. 
Patients who completed their treatment slightly 
increased from 7.41% in September 2010-August 
2011 to 9.26 % in September 2011-August 2012. 
However, there was a decrement to 8.02% in 
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Table 2: Prevalence of TB in Debrebirhan prison, North Shoa Ethiopia; September 2010 – August 2015 
 (n   =  162) 
 
 
Year  Number of 
inmates 
All TB cases: 
N (%)  
Prevalence (per 100,000 
inmates) 
September 2010-August  2011 1203 29  (17.9) 2411 
September 2011- August 2012 1410 36 (22.2) 2553 
September 2012- August 2013 1682 38 (23.5) 2259 
September 2013- August 2014 1701 33 (20.4) 1940 
September 2014- August 2015 1695 26 (16.0) 1534 
Total  7691 162 (100.0) 10697 
    
Table 3: Treatment outcomes across the years for all cases of tuberculosis in Debrebirhan prison, North 




Year of Treatment 









Sep 2010- Aug 2011 5 (3.09%) 12 (7.41%) 1 (0.62%) 9 (5.56%) 2 (1.24%) 29 (17.90%) 
Sep 2011- Aug 2012 10 (6.17%) 15 (9.26%) 0 (0.00%) 10 (6.17%) 1 (0.62%) 36 (22.22%) 
Sep2012- Aug 2013 10 (6.17%) 13 (8.02%) 1 (0.62%) 12 (7.41%) 2 (1.24%) 38 (23.46%) 
Sep 2013- Aug 2014 12 (7.41%) 8 (4.94%) 0 (0.00%) 12 (7.41%) 1 (0.62%) 33 (20.37%) 
Sep 2014- Aug 2015 7 (4.32%) 11 (6.79%) 0 (0.00%) 8 (4.94%) 0 (0.00) 26 (16.05%) 
        Total 44(27.2%) 59 (36.42%) 2 (1.24%) 51(31.49%) 6 (3.72%) 162(100.0%) 
Note: Sep stands for September and Aug stands for August 
 
Predictors of TB treatment outcome in prison: 
Multivariable logistic regression model was 
employed to explore the association between 
treatment outcome and potential predictor 
variables. Accordingly, area of residence before 
imprisonment, duration of imprisonment and 
previous TB history were found to have 
statistically significant association with TB 
treatment outcome of the prisoners. The odds of 
successful treatment outcome was 3.59 times 
(AOR = 3.59; 95% CI: 1.44-8.93) significantly 
higher among urban resident TB patients as 
compared to rural residents. Duration of 
imprisonment was significantly associated with 
treatment success where those patients imprisoned 
for two or less years had 3.67 times (AOR = 3.67; 
95% CI: 1.53, 8.78) greater success of treatment 
outcome than those who were in prison for more 
than two years. Prisoners’ age, HIV status and TB 
type did not show any statistically significant 




This study assessed the prevalence of tuberculosis 
and treatment outcomes of patients with tuberculosis 
among inmates of Debrebirhan prison, North Shoa, 
Ethiopia. It has been reported that prevalence rates of 
TB in prisons are usually higher than national 
averages (6). This was reflected in this study by the 
high prevalence rate of TB ranging from 1534 to 
2553 per 100,000 inmates in the five years period. 
The overall TB prevalence in this prison was found 
to be 2,139 per 100,000 inmates which was much 
higher than the prevalence reported by WHO in 2015 
for the general Ethiopian population, estimated to be 
200 per 100,000 populations (1). The high TB 
prevalence rate observed in this study was also in 
line with the previous studies of TB prevalence in 
other prisons of Ethiopia and other countries. High 
TB prevalence was reported in  ten years
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Table 4:  Predictors of treatment outcomes of patients with TB in Debrebirhan prison, North Shoa Ethiopia; 












Age group (in years) 













1.20 (0.56, 2.57) 
1.86 (0.69, 4.97) 
0.93 (0.32, 2.71) 
1.0 
1.43 (0.57, 3.59) 
1.79 (0.54, 5.95) 
2.19 (0.60, 7.95) 
Educational status 











4.29 (2.08, 8.89) 
1.0 
2.36 (0.99, 5.61) 
2.72(0.61, 12.36) 
Residence  







6.62 (2.95, 14.86)* 
1.0 
3.59 (1.44, 8.93)* 
Duration of  Imprisonment  







5.84 (2.67, 12.77)* 
1.0 
3.67 (1.53, 8.78)* 
TB history 







6.0 (1.56, 23.15)* 
1.0 
1.52 (1.03, 23.78)* 











0.91 (0.45, 1.83) 
0.68 (0.26, 1.76) 
1.0 
1.03 (0.43, 2.45) 
0.91 (0.30, 2.72) 
HIV status  
 Positive  
Unknown 








4.0 (0.66, 24.21) 




*Significance at p < 0.05, COR: crude odds ratio, AOR: adjusted odds ratio, CI: confidence interval 
 
retrospective study of North Gondar Zone prison 
which ranged from 579/100,000 to 2623/100,000 
prisoners (11). However, a relatively lower 
prevalence (458.1 per 100,000 inmates) was 
reported in Northern and Eastern Ethiopian 
prisons (13). This might be due to the difference in 
sample size. Similarly, high TB prevalence was 
also observed in prisons of other African countries 
such as South African with prevalence of 
8772/100,000 prisoners (12) and Ugandan prison 
with prevalence of 955/100,000 inmates (14), 
Tanzania (4,000), Malawi (1,080), and Zambia 
(2,200) per 100,000 populations (15).  
The trend of TB prevalence in this study 
showed that there was a steady decrement over the 
last four study periods except in September 2011- 
August 2012. This might be associated with the 
decline of TB prevalence in the general population 
observed in Ethiopia in the last five years (1,3). 
The national TB survey of 2010/2011 reported a 
TB prevalence of 277/100,000 population (3), 
while in 2013 the prevalence of TB in the general 
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population was declined to 211/100,000, then to 
200/100,000 in 2015(1).   
The treatment success rate found in this study 
was 63.42% which is lower than that of WHO 
international target of at least 85% (1). It is also 
lower than the national TB treatment success 
target set in the fourth Health Sector Development 
Program, which is 90% to be achieved by 2014/15 
(16). The treatment success of this study is also 
moderately lower than the one done in Debre 
Berhan Hospital which was 79.4% (9).  
This study revealed that 44(27.2%) of the 
patients were cured, 59(36.42%) treatment 
completed, 2(1.24%) treatment failures (one of 
these was found to be MDR TB), 6(3.72%) died, 
and 51(31.49%) not evaluated. In this study, the 
cure rate is lower than that of a study conducted in 
El Salvador prison which was found to be 90.0% 
(17). Another research conducted in Debre Berhan 
Hospital found that 203(20%) and 813(80%) 
patients were cured and treatment completed, 
respectively. The low treatment success rate could 
be explained by the high transferred-out rate 
(31.5%) of the TB patients to another prison or 
being freed from prison before completing their 
treatment.  Since there was no system to trace and 
follow the final treatment outcome of the 
transferred-out patients, their treatment outcome 
was not evaluated and there could be a chance that 
they might end-up with treatment failure or death. 
If treatment failure could be the outcome, 
development and spread of drug resistant TB to 
the community could be the immediate 
consequence (11). 
The multivariable logistic regression of this 
study revealed that TB treatment outcome was 
associated with area of residence, duration of 
imprisonment and previous history of TB. The 
odds of successful treatment outcome was 
significantly higher among urban residents than 
among rural residents (AOR=3.59, 95% CI: 1.44-
8.93) which might be due to the fact that patients 
from urban area might have better awareness on 
TB treatment (18,19). Furthermore, patients who 
had lower duration of stay in the prison reported to 
have more favorable treatment outcomes 
(AOR=3.67, 95% CI: 1.53-8.78) than their 
counterparts. This could be explained by the 
psychological distress, which may affect the 
adherence to the treatment being worse in 
prisoners who stayed longer in the prison than in 
those who stayed shorter (6,20). A study 
conducted in Brazilian prisons showed that 
treatment category of TB was associated with 
treatment outcome of patients (21). Similar to this 
finding, one study conducted in an Ethiopian 
university hospital found that undergoing previous 
retreatment was significantly associated with 
treatment outcome (22).   
Although this study has a significant input 
for researchers and policy makers, there is a 
limitation in that it was based on secondary data  
that it was not able to assess factors of TB 
treatment outcome that are related to the patients, 
the health care providers and the health service. 
This study revealed high prevalence of TB in 
Debrebirhan prison. It also revealed that the 
treatment success rate of tuberculosis patients 
was lower than the target set by the World Health 
Organization. Hence, the prison authority 
together with regional and/or national TB control 
programs should develop locally feasible 
interventions to reduce the transmission and 
establish efficient referral and contact tracing 
mechanisms for transferred-out cases. The direct 
observation therapy program should also be 
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